Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 5
1979 5
1980 5
1981 9
1982 16
1983 22
1984 12
1985 6
1986 5
1987 3
1988 10
1989 7
1990 4
1991 9
1992 3
1993 11
1994 5
1995 5
1996 4
1997 5
1998 7
1999 10
2000 11
2001 6
2002 8
2003 5
2004 4
2005 5
2006 7
2007 6
2008 4
2009 5
2010 5
2011 10
2012 8
2013 6
2014 19
2015 34
2016 15
2017 4
2018 4
2019 8
2020 3
2021 7
2022 7
2023 7
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

347 results

Results by year

Filters applied: . Clear all
Page 1
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference.
Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, Cash DM, Thomas DL, Dick KM, Cardoso J, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, de Mendonça A, Sorbi S, Warren JD, Crutch S, Fox NC, Ourselin S, Schott JM, Rohrer JD, Alexander DC; Genetic FTD Initiative (GENFI); Alzheimer’s Disease Neuroimaging Initiative (ADNI). Young AL, et al. Nat Commun. 2018 Oct 15;9(1):4273. doi: 10.1038/s41467-018-05892-0. Nat Commun. 2018. PMID: 30323170 Free PMC article.
A Cognitive Biotype of Depression and Symptoms, Behavior Measures, Neural Circuits, and Differential Treatment Outcomes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Hack LM, Tozzi L, Zenteno S, Olmsted AM, Hilton R, Jubeir J, Korgaonkar MS, Schatzberg AF, Yesavage JA, O'Hara R, Williams LM. Hack LM, et al. Among authors: yesavage ja. JAMA Netw Open. 2023 Jun 1;6(6):e2318411. doi: 10.1001/jamanetworkopen.2023.18411. JAMA Netw Open. 2023. PMID: 37318808 Free PMC article. Clinical Trial.
An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer's disease.
Jiang Y, Zhou X, Wong HY, Ouyang L, Ip FCF, Chau VMN, Lau SF, Wu W, Wong DYK, Seo H, Fu WY, Lai NCH, Chen Y, Chen Y, Tong EPS; Alzheimer’s Disease Neuroimaging Initiative; Mok VCT, Kwok TCY, Mok KY, Shoai M, Lehallier B, Losada PM, O'Brien E, Porter T, Laws SM, Hardy J, Wyss-Coray T, Masters CL, Fu AKY, Ip NY. Jiang Y, et al. Nat Aging. 2022 Jul;2(7):616-634. doi: 10.1038/s43587-022-00241-9. Epub 2022 Jul 15. Nat Aging. 2022. PMID: 37117777 Free PMC article.
Geriatric Depression Scale.
Yesavage JA. Yesavage JA. Psychopharmacol Bull. 1988;24(4):709-11. Psychopharmacol Bull. 1988. PMID: 3249773 No abstract available.
Gender differences in moderate drinking effects.
Mumenthaler MS, Taylor JL, O'Hara R, Yesavage JA. Mumenthaler MS, et al. Among authors: yesavage ja. Alcohol Res Health. 1999;23(1):55-64. Alcohol Res Health. 1999. PMID: 10890798 Free PMC article. Review.
Deep learning-based polygenic risk analysis for Alzheimer's disease prediction.
Zhou X, Chen Y, Ip FCF, Jiang Y, Cao H, Lv G, Zhong H, Chen J, Ye T, Chen Y, Zhang Y, Ma S, Lo RMN, Tong EPS; Alzheimer’s Disease Neuroimaging Initiative; Mok VCT, Kwok TCY, Guo Q, Mok KY, Shoai M, Hardy J, Chen L, Fu AKY, Ip NY. Zhou X, et al. Commun Med (Lond). 2023 Apr 6;3(1):49. doi: 10.1038/s43856-023-00269-x. Commun Med (Lond). 2023. PMID: 37024668 Free PMC article.
347 results